Terns Pharmaceuticals Inc (TERN) earnings · $6.12B cap
These earnings events as JSON? API free 100/dayTerns Pharmaceuticals Inc (TERN) is a biotechnology company listed on NASDAQ.
This TERN earnings page is the cached print — revenue, income, and the latest exhibit — not a live call transcript.
Latest reported TERN revenue for 2022-12-31 was $0. Net income was -$60.3M. Revenue was down 100.0% from 2021-12-31 to 2022-12-31. TERN currently screens at market cap $6.12B.
When the next TERN 8-K Item 2.02 lands, this page should move. Until then the SEC archive is the source.
The change that matters: Revenue was down 100.0% from 2021-12-31 to 2022-12-31. An earnings headline that ignores that move is noise.
Not investment advice. Full TERN research stays on the stock page; the tape stays on the quote page.
TERN earnings FAQ
What is TERN's latest net income?
Latest cached Terns Pharmaceuticals Inc (TERN) net income was -$60.3M. Statements: https://lician.com/financials/tern
What is TERN's latest diluted EPS?
Latest cached Terns Pharmaceuticals Inc (TERN) diluted EPS for Dec 31, 2022 was -$1.67.
What period does the latest TERN earnings print cover?
The latest cached Terns Pharmaceuticals Inc (TERN) earnings print covers Dec 31, 2022. The prior cached period on this page is Dec 31, 2021.
Where are TERN earnings listed?
Cached earnings facts for Terns Pharmaceuticals Inc (TERN) are listed at https://lician.com/earnings/tern. Statements: https://lician.com/financials/tern
Not investment advice.